Skip to main content

Proteome in Leukemic vs. Differentiated Leukemia Cells

  • Chapter
  • First Online:
Epigenetics and Proteomics of Leukemia

Abstract

We exploited the proteomic approach to identify proteins whose expression changed during leukemia cell differentiation. The determination of protein expression differences in leukemia and normal blood cells can help identify novel cancer signaling mechanisms. In Chap. 4 are presented proteomic studies in order to identify proteins characteristic for AML cells and significantly altered during granulocytic differentiation and/or its leading apoptosis. Computational comparative proteome analysis of CD34+, mature neutrophils, leukemia cells and cells induced to differentiation or apoptosis is presented and identified proteins likelihood important to a potential therapeutic target for AML.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F, Rocha K, Kumaraswamy S, Boyapalle S, Atadja P, Seto E, Bhalla K (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90—A novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 280(29):26729–26734. https://doi.org/10.1074/jbc.C500186200

    Article  CAS  Google Scholar 

  • Borutinskaite V, Navakauskiene R (2015) The histone deacetylase inhibitor BML-210 influences gene and protein expression in human promyelocytic leukemia NB4 cells via epigenetic reprogramming. Int J Mol Sci 16(8):18252–18269. https://doi.org/10.3390/ijms160818252

    Article  CAS  Google Scholar 

  • Borutinskaite V, Magnusson KE, Navakauskiene R (2005) Effects of retinoic acid and histone deacetilase inhibitor Bml-210 on protein expression in NB4 cells. Biologija 4:88–93

    Google Scholar 

  • Borutinskaite VV, Magnusson KE, Navakauskiene R (2011) α-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation. Mol. Biol. Rep. 38(5):3001–3011. https://doi.org/10.1007/s11033-010-9965-9

    CAS  Google Scholar 

  • Breitman TR, Selonick SE, Collins SJ (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77(5):2936–2940. https://doi.org/10.1073/pnas.77.5.2936

    Article  CAS  Google Scholar 

  • Collins SJ (1987) The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70(5):1233–1244

    Article  CAS  Google Scholar 

  • Collins SJ, Gallo RC, Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270(5635):347–349

    Article  CAS  Google Scholar 

  • Geering B, Simon HU (2011) Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ 18(9, SI):1457–1469. https://doi.org/10.1038/cdd.2011.75

  • Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C (2012) Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models. Int J Oncol 40(3):711–720. https://doi.org/10.3892/ijo.2011.1270

    CAS  PubMed  Google Scholar 

  • Grebenova D, Roeselova P, Pluskalova M, Halada P, Roesel D, Suttnar J, Brodska B, Otevrelova P, Kuzelova K (2012) Proteins implicated in the increase of adhesivity induced by suberoylanilide hydroxamic acid in leukemic cells. J Proteomics 77:406–422. https://doi.org/10.1016/j.jprot.2012.09.014

    Article  CAS  Google Scholar 

  • Heller T, Asif AR, Petrova DT, Doncheva Y, Wieland E, Oellerich M, Shipkova M, Armstrong VW (2009) Differential proteomic analysis of lymphocytes treated with mycophenolic acid reveals caspase 3-induced cleavage of rho GDP dissociation inhibitor 2. Ther Drug Monit 31(2):211–217. https://doi.org/10.1097/FTD.0b013e318196fb73

    Article  CAS  Google Scholar 

  • Hunter T (1995) Protein-kinases and phosphatases—the yin and yang of protein-phosphorylation and signaling. CELL 80(2):225–236. https://doi.org/10.1016/0092-8674(95)90405-0

    Article  CAS  Google Scholar 

  • Karin M, Liu ZG, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9(2):240–246. https://doi.org/10.1016/S0955-0674(97)80068-3

    Article  CAS  Google Scholar 

  • Kashyap AS, Fernandez-Rodriguez L, Zhao Y, Monaco G, Trefny MP, Yoshida N, Martin K, Sharma A, Olieric N, Shah P, Stanczak M, Kirchhammer N, Park SM, Wieckowski S, Laubli H, Zagani R, Kasenda B, Steinmetz MO, Reinecker HC, Zippelius A (2019) GEF-H1 signaling upon microtubule destabilization is required for dendritic cell activation and specific anti-tumor responses. Cell Rep 28(13):3367+. https://doi.org/10.1016/j.celrep.2019.08.057

  • Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, etal (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409(2):581–589

    Article  CAS  Google Scholar 

  • Kulyte A, Navakauskiene R, Treigyte G, Gineitis A, Magnusson KE (2001) Parallel assessment of tyrosine phosphorylation and nuclear targeting of proteins. Biotechniques 31(3):510, 512–4, 517

    Google Scholar 

  • Kulyte A, Navakauskiene R, Treigyte G, Gineitis A, Bergman T, Magnusson KE (2002) Characterization of human alpha-dystrobrevin isoforms in HL-60 human promyelocytic leukemia cells undergoing granulocytic differentiation. Mol Biol Cell 13(12):4195–4205. https://doi.org/10.1091/mbc.E02-03-0128

    Article  CAS  Google Scholar 

  • Lim MJ, Wang XW (2006) Nucleophosmin and human cancer. CAncer Detect Preven 30(6):481–490. https://doi.org/10.1016/j.cdp.2006.10.008

    Article  CAS  Google Scholar 

  • Matuzevicius D, Zurauskas E, Navakauskiene R, Navakauskas D (2008) Improved proteomic characterization of human myocardium and heart conduction system by using computational methods. Biologija 4:283–289

    Article  Google Scholar 

  • Navakauskiene R, Treigyte G, Pivoriunas A, Savickiene J (2002) Cell cycle inhibitors in retinoic acid- and etoposide-mediated biological responses. Biologija 2:64–67

    Google Scholar 

  • Navakauskiene R, Kulyte A, Treigyte G, Gineitis A, Magnusson KE (2003a) Translocation of transcription regulators into the nucleus during granulocyte commitment of HL-60 cells. Biochem Cell Biol.-Biochim et Biol Cell 81(4):285–295. https://doi.org/10.1139/O03-055

    Article  CAS  Google Scholar 

  • Navakauskiene R, Treigyte G, Kulyte A, Magnusson KE (2003b) Proteomic analysis by MALDI-TOf mass spectrometry and its application to HL-60 cells. Biologija 3:63–65

    Google Scholar 

  • Navakauskiene R, Treigyte G, Gineitis A, Magnusson KE (2004a) Identification of apoptotic tyrosine-phosphorylated proteins after etoposide or retinoic acid treatment of HL-60 cells. Proteomics 4(4):1029–1041. https://doi.org/10.1002/pmic.200300671

    Article  CAS  Google Scholar 

  • Navakauskiene R, Treigyte G, Savickiene J, Gineitis A, Magnusson KE (2004b) Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk. In: Diederich M (ed) Signal Transduction Pathways, Chromatin Structure, and Gene Expression Mechanisms as Therapeutic Targets, Fdn Rech Canc & Sang; Novartis Luxembourg; Q8 Petr, Annals of the New York Academy of Sciences, vol 1030, pp 393–402. https://doi.org/10.1196/annals.1329.0049

  • Navakauskiene R, Treigyte G, Borutinskaite VV, Matuzevicius D, Navakauskas D, Magnusson KE (2012) Alpha-dystrobrevin and its associated proteins in human promyelocytic leukemia cells induced to apoptosis. J Proteomics 75(11):3291–3303. https://doi.org/10.1016/j.jprot.2012.03.041

    Article  CAS  Google Scholar 

  • Navakauskiene R, Borutinskaite VV, Treigyte G, Savickiene J, Matuzevicius D, Navakauskas D, Magnusson KE (2014) Epigenetic changes during hematopoietic cell granulocytic differentiation—comparative analysis of primary CD34+cells, KG1 myeloid cells and mature neutrophils. BMC Cell Biol 15:4. https://doi.org/10.1186/1471-2121-15-4

    Article  Google Scholar 

  • Nawarak J, Huang-Liu R, Kao SH, Liao HH, Sinchaikul S, Chen ST, Cheng SL (2009) Proteomics analysis of A375 human malignant melanoma cells in response to arbutin treatment. Biochim Biophys Acta Proteins Proteomics 1794(2):159–167. https://doi.org/10.1016/j.bbapap.2008.09.023

    Article  CAS  Google Scholar 

  • Patterson C, Portbury AL, Schisler JC, Willis MS (2011) Tear me down role of calpain in the development of cardiac ventricular hypertrophy. Circ Res 109(4):453–462. https://doi.org/10.1161/CIRCRESAHA.110.239749

    Article  CAS  Google Scholar 

  • Pawson T (1995) Protein modules and signaling networks. Nature 373(6515):573–580. https://doi.org/10.1038/373573a0

    Article  CAS  Google Scholar 

  • Savickiene J, Treigyte G, Valiuliene G, Stirblyte I, Navakauskiene R (2014) Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells. Anti-Cancer Drugs 25(8):938–949. https://doi.org/10.1097/CAD.0000000000000122

    Article  CAS  Google Scholar 

  • Sheng W, Chen C, Dong M, Zhou J, Liu Q, Dong Q, Li F (2014) Overexpression of calreticulin contributes to the development and progression of pancreatic cancer. J Cell Physiol 229(7):887–897. https://doi.org/10.1002/jcp.24519

    Article  CAS  Google Scholar 

  • Sporn MB, Roberts AB, Goodman DS (1994) The retinoids: biology, chemistry, and medicine. Raven Press, New York

    Google Scholar 

  • Treigyte G, Navakauskiene R, Kulyte A, Gineitis A, Magnusson KE (2000a) Characteristics of cytosolic proteins and changes in their tyrosine phosphorylation during HL-60 cell differentiation. Biologija 2:32–35

    Google Scholar 

  • Treigyte G, Navakauskiene R, Kulyte A, Gineitis A, Magnusson KE (2000b) Tyrosine phosphorylation of cytoplasmic proteins in proliferating, differentiating, apoptotic HL-60 cells and blood neutrophils. Cell Mol Life Sci 57(13–14):1997–2008. https://doi.org/10.1007/PL00000681

    Article  CAS  Google Scholar 

  • Treigyte G, Savickiene J, Navakauskiene R (2004) Identification of O- and N-glycosylated nuclear proteins of HL-60 cells induced to granulocytic differentiation. Biologija 2:49–51

    Google Scholar 

  • Valiuliene G, Stirblyte I, Cicenaite D, Kaupinis A, Valius M, Navakauskiene R (2015) Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling. J Cell Mol Med 19(7):1742–1755. https://doi.org/10.1111/jcmm.12550

    Article  CAS  Google Scholar 

  • Valiulienė G, Treigytė G, Savickienė J, Matuzevičius D, Alksnė M, Jarašienė-Burinskaja R, Bukelskienė V, Navakauskas D, Navakauskienė R (2016) Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy. Biomed. Pharmacother. 79:62–70. https://doi.org/10.1016/j.biopha.2016.01.044

    Article  Google Scholar 

  • Valiuliene G, Stirblyte I, Jasnauskaite M, Borutinskaite V, Navakauskiene R (2017) Anti-leukemic effects of HDACi belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells. Eur J Pharmacol 799:143–153. https://doi.org/10.1016/j.ejphar.2017.02.014

    Article  CAS  Google Scholar 

  • Vitkeviciene A, Skiauteryte G, Zucenka A, Stoskus M, Gineikiene E, Borutinskaite V, Griskevicius L, Navakauskiene R (2019) HDAC and HMT inhibitors in combination with conventional therapy: a novel treatment option for acute promyelocytic leukemia. J. Oncol. 2019:11. https://doi.org/10.1155/2019/6179573

    Article  Google Scholar 

  • Witter DJ, Belvedere S, Chen L, Secrist JP, Mosley RT, Miller TA (2007) Benzo[b]thiophene-based histone deacetylase inhibitors. Bioorg Med Chem Lett 17(16):4562–4567. https://doi.org/10.1016/j.bmcl.2007.05.091

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Navakauskienė, R., Navakauskas, D., Borutinskaitė, V., Matuzevičius, D. (2021). Proteome in Leukemic vs. Differentiated Leukemia Cells. In: Epigenetics and Proteomics of Leukemia. Springer, Cham. https://doi.org/10.1007/978-3-030-68708-3_4

Download citation

Publish with us

Policies and ethics